Status
Conditions
Treatments
About
Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, metastases, and/or death
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adults >18 years old at time of consent
Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
Patients with carcinoma in situ or invasive breast cancer
Patient must be undergoing one of the following:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 1 patient group
Loading...
Central trial contact
Nicole Simone, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal